» Articles » PMID: 35132382

Optimal Decision Theory for Diagnostic Testing: Minimizing Indeterminate Classes with Applications to Saliva-Based SARS-CoV-2 Antibody Assays

Overview
Journal ArXiv
Date 2022 Feb 8
PMID 35132382
Authors
Affiliations
Soon will be listed here.
Abstract

In diagnostic testing, establishing an indeterminate class is an effective way to identify samples that cannot be accurately classified. However, such approaches also make testing less efficient and must be balanced against overall assay performance. We address this problem by reformulating data classification in terms of a constrained optimization problem that (i) minimizes the probability of labeling samples as indeterminate while (ii) ensuring that the remaining ones are classified with an average target accuracy X. We show that the solution to this problem is expressed in terms of a bathtub principle that holds out those samples with the lowest local accuracy up to an X-dependent threshold. To illustrate the usefulness of this analysis, we apply it to a multiplex, saliva-based SARS-CoV-2 antibody assay and demonstrate up to a 30 % reduction in the number of indeterminate samples relative to more traditional approaches.

References
1.
Theel E, Harring J, Hilgart H, Granger D . Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2. J Clin Microbiol. 2020; 58(8). PMC: 7383546. DOI: 10.1128/JCM.01243-20. View

2.
Bottcher L, DOrsogna M, Chou T . A statistical model of COVID-19 testing in populations: effects of sampling bias andtesting errors. Philos Trans A Math Phys Eng Sci. 2021; 380(2214):20210121. PMC: 8607147. DOI: 10.1098/rsta.2021.0121. View

3.
Hachim A, Kavian N, Cohen C, Chin A, Chu D, Mok C . ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection. Nat Immunol. 2020; 21(10):1293-1301. DOI: 10.1038/s41590-020-0773-7. View

4.
Bond K, Nicholson S, Lim S, Karapanagiotidis T, Williams E, Johnson D . Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting. J Infect Dis. 2020; 222(8):1280-1288. PMC: 7454699. DOI: 10.1093/infdis/jiaa467. View

5.
Manthei D, Whalen J, Schroeder L, Sinay A, Li S, Valdez R . Differences in Performance Characteristics Among Four High-Throughput Assays for the Detection of Antibodies Against SARS-CoV-2 Using a Common Set of Patient Samples. Am J Clin Pathol. 2020; 155(2):267-279. PMC: 7665294. DOI: 10.1093/ajcp/aqaa200. View